Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis von Surov, Alexey, Pech, Maciej, Gessner, Daniel, Mikusko, Martin, Fischer, Thomas, Alter, Mareike, Wienke, Andreas

Volltext

Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial von Al-Sawaf, Othman, Ligtvoet, Rudy, Robrecht, Sandra, Stumpf, Janina, Fink, Anna-Maria, Tausch, Eugen, Schneider, Christof, Boettcher, Sebastian, Mikusko, Martin, Ritgen, Matthias, Schetelig, Johannes, von Tresckow, Julia, Vehling-Kaiser, Ursula, Gaska, Tobias, Wendtner, Clemens Martin, Chapuy, Bjoern, Fischer, Kirsten, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Staber, Philipp, Niemann, Carsten, Hallek, Michael, Eichhorst, Barbara

Volltext

Tislelizumab Plus Zanubrutinib in Patients with Richter Transformation: Primary Endpoint Analysis of the Prospective, Multi-Center, Phase-II RT1 Trial of the German CLL Study Group von Al-Sawaf, Othman, Ligtvoet, Rudy, Robrecht, Sandra, Stumpf, Janina, Fink, Anna Maria, Tausch, Eugen, Schneider, Christof, Böttcher, Sebastian, Mikusko, Martin, Ritgen, Matthias, Schetelig, Johannes, Von Tresckow, Julia, Vehling-Kaiser, Ursula, Wendtner, Clemens-Martin, Fischer, Kirsten, Kreuzer, Karl Anton, Stilgenbauer, Stephan, Staber, Philipp Bernhard, Niemann, Carsten Utoft, Hallek, Michael, Eichhorst, Barbara F.

Volltext

Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantation von Barajas Ordonez, Felix, Zeller, Yannic, Wolleschak, Denise, Hinnerichs, Mattes, Rodríguez-Feria, Pablo, Mougiakakos, Dimitrios, Aghayev, Anar, Kardas, Hakan, Mikusko, Martin, Borggrefe, Jan, Surov, Alexey

Volltext